Back
EyePoint Pharmaceuticals Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
58
EYPT
EyePoint Pharmaceuticals
Last Price:
11.78
Seasonality Move:
5.46%
7 Day Trial
ALL ACCESS PASS
$
7
"If I Had To Start Again..." Expert Reveals #1 Investing Hack
In his latest free guide, Duffy reveals... click here to continue reading...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight selling pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.7 | Buy |
| 20-day SMA: | 9.79 | Buy |
| 50-day SMA: | 9.04 | Buy |
| 200-day SMA: | 14.83 | Sell |
| 8-day EMA: | 10.83 | Buy |
| 20-day EMA: | 10.07 | Buy |
| 50-day EMA: | 9.49 | Buy |
| 200-day EMA: | 11.64 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 62.51 | Buy |
| Chaikin Money Flow: | -1019841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.12 - 10.76) | Buy |
| Bollinger Bands (100): | (8.09 - 9.87) | Buy |
EyePoint Pharmaceuticals Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.45 while EYPT 8-day simple moving average is 10.70, which is a Buy signal.
- The stock price of EYPT is 11.45 while EyePoint Pharmaceuticals 20-day SMA is 9.79, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 9.04 while EYPT share price is 11.45, making it a Buy technically.
- EYPT stock price is 11.45 and EyePoint Pharmaceuticals 200-day simple moving average is 14.83, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
58
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $11.45. The Score for EYPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
612.78M
Price in USD:
11.45
Share Volume:
4.14M
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.74
Buy
58
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 11.45 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 11.45 while EYPT 8-day exponential moving average is 10.83, which is a Buy signal.
- The stock price of EYPT is 11.45 while EyePoint Pharmaceuticals 20-day EMA is 10.07, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.49 while EYPT share price is 11.45, making it a Buy technically.
- EYPT stock price is 11.45 and EyePoint Pharmaceuticals 200-day simple moving average is 11.64, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.84 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting EyePoint Pharmaceuticals is a Buy
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 62.51, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.12 - 10.76), which suggest EyePoint Pharmaceuticals is a Buy
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (8.09 - 9.87), which suggest EyePoint Pharmaceuticals is a Buy
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.